InflaRx (IFRX) Cash from Financing Activities (2016 - 2026)

InflaRx has disclosed Cash from Financing Activities across 11 years of filings, most recently posting -$87443.0 for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$87443.0, down 100.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.3 million (down 74.9% YoY), and the FY2025 annual result was $38.8 million, up 9291.36% from the prior year.
• Cash from Financing Activities came in at -$87443.0 for Q1 2026 at InflaRx, down from $7.6 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $57.9 million in Q2 2023 to a low of -$115600.7 in Q2 2024.
• The 5-year median for Cash from Financing Activities is -$93107.7 (2024), against an average of $5.6 million.
• Across the five-year window, Cash from Financing Activities soared 59562.31% in 2023 and sank 387.22% in 2024, its largest moves.
• InflaRx's Cash from Financing Activities stood at $2.3 million in 2022, then slumped by 104.53% to -$102107.8 in 2023, then surged by 808.08% to $723002.0 in 2024, then jumped by 945.21% to $7.6 million in 2025, then plunged by 101.16% to -$87443.0 in 2026.
• The last three Cash from Financing Activities figures came in at -$87443.0 (Q1 2026), $7.6 million (Q4 2025), and -$99314.7 (Q3 2025), per Business Quant data.